Although ablation of CD8+ T cells in AD mice did not reduce Aβ deposition and cognitive deficits in APP-PS1 mice at later disease stages, recent studies suggested that CD8+ T cells migrate in the brain parenchyma in subjects with AD and its mouse models (15, 127) (Figure 2). The gene discussed is CD8A; the disease is Alzheimer disease.